IP Library Granted Patent US 11,066,645
Granted Patent B2
US 11,066,645 · App. 15/859,375 · Granted Jul 20, 2021

Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom

Inventor: Toan-Thang Phan (Singapore, SG)
Assignee: CELLRESEARCH CORPORATION PTE LTD.
C12N5/0655A61K35/32A61L27/18A61L27/3633A61L27/3804A61L27/3839A61L27/56A61L27/60C12N5/0605C12N5/0629C12N5/0668C12N5/0676C12N5/0698C12N2501/11C12N2501/115C12N2502/094C12N2502/1323C12N2506/02C12N2506/1369C12N2533/54
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,066,645
App. No.
15/859,375
Granted
Jul 20, 2021
Kind
B2
Abstract

The present invention relates to a method of promoting skin rejuvenation in a subject. The method comprises administering to the subject an effective amount of a cellular extract of epithelial or mesenchymal stem/progenitor cells isolated from the amniotic membrane of the umbilical cord, wherein the cellular extract contains growth factors and peptides and is in the form of a supernatant into which the epithelial or mesenchymal stem/progenitor cells secrete the growth factors and peptides.

Claims (6)

1. A cosmetic method comprising:

topically applying to an intact skin surface of a human subject a cellular extract of mesenchymal stem/progenitor cells isolated from the amniotic membrane of human umbilical cord in liquid or viscous form, as an agent for promoting cell proliferation of skin keratinocytes and human dermal fibroblasts, wherein the cellular extract is in the form of a supernatant into which the mesenchymal stem/progenitor cells have secreted growth factors and peptides and wherein the mesenchymal stem/progenitor cells express the following genes:

POU5f1, Bmi-1, leukemia inhibitory factor (LIF), and secrete Activin A and Follistatin.

2. The method of claim 1 , wherein the cellular extract is administered in a topical formulation selected from the group consisting of an ointment, a cream, and a lotion.

3. The method of claim 1 , wherein the subject is as old or older than 35 years, 40 years, 50 years, 60 years or 70 years.

4. A cosmetic method of claim 1 , wherein the skin surface is an age-damaged skin surface of the human subject.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2018
From: PHAN, TOAN-THANG
To: CELLRESEARCH CORPORATION PTE LTD.
Reel/Frame 045333/0836 →
Continuity (5)
Continuation 14715342 · May 18, 2015
Division 13652371 · Oct 15, 2012
Division 12091018
Provisional Application 60729172 · Oct 21, 2005
Related Publication 20180119103A1 · May 3, 2018
Cited By (1)
US 12,492,373